Manas AI
Drug Discovery · Artificial Intelligence
Overview
Manas AI is the AI-native biopharmaceutical company. We combine pioneering AI technology with the first principles of chemistry, physics and biology to transform the clinical pipeline from target to medicine.
Funding and backers
Backers
3
Endeavor, General Catalyst
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
Extended-release RNA medicines that turn transient treatments into durable therapies for chronic disease. ScionxBio uses synthetic…
EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics.
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Retro Biosciences develops therapies that target aging biology to extend healthy human lifespan by 10 years.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Mosaic VenturesVia a fund
General CatalystVia a fund
610 portfolio companies
EndeavorVia a fund
1353 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely